Ewing Sarcoma is a developmental tumor characterized by balanced chromosomal translocations and formation of new fusion genes, which are the main hallmark of this rare entity. Despite the vast knowledge regarding the molecular aspects of this rare malignancy obtained in the last few years, including the discovery of new therapeutic targets, many questions still remain open. In this review we focus on the research on targeted therapies in this malignancy, and discussed some bottlenecks related to this such as the possible role of pathologists, the availability of samples, the lack of appropriate animal models, and the resources needed to carry out preclinical and clinical research.
机构:
Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USAChildrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
Balamuth, Naomi J.
Womer, Richard B.
论文数: 0引用数: 0
h-index: 0
机构:
Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USAChildrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA